Search
for
Sort by
Research 811–840 of 1000+
- Role of insulin, insulin‐like growth factor‐1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Neuregulin3 alters cell fate in the epidermis and mammary gland
- Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.
- VEGF upregulates VEGF receptor-2 on human outer root sheath cells and stimulates proliferation through ERK pathway
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Discoid lupus erythematosus successfully treated with deucravacitinib
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- “PRIDE” Complex
- Structure-guided PEGylated fibroblast growth factor 2 variants accelerate wound healing with improved stability
- Adrenal myelolipoma: A rare entity
- Review of Promising Off-Label Use of Deucravacitinib
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Transarterial chemoembolization (TACE) combined with donafenib as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A real-world clinical study.
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Differential dependency of unmyelinated and A delta epidermal and upper dermal innervation on neurotrophins, trk receptors, and p75LNGFR.
- A subpopulation of itch‐sensing neurons marked by Ret and somatostatin expression
- Sprouty/FGF signaling regulates the proximal–distal feather morphology and the size of dermal papillae
- Epigen Transgenic Mice Develop Enlarged Sebaceous Glands
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Erlotinib-Induced Skin Inflammation Is IL-1 Mediated in KC-Tie2 Mice and Human Skin Organ Culture
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- Advancing Design Strategy of PROTACs for Cancer Therapy
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- Potential Consequences of the Use of Adipose-Derived Stem Cells in the Treatment of Hepatocellular Carcinoma
- GDNF neurotrophic factor signaling determines the fate of dermal fibroblasts in wound‐induced hair neogenesis and skin regeneration